Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Covington
Citi
Farmers Insurance
Johnson and Johnson
Chinese Patent Office
Mallinckrodt
Argus Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020816

« Back to Dashboard

NDA 020816 describes AZOPT, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. Additional details are available on the AZOPT profile page.

The generic ingredient in AZOPT is brinzolamide. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the brinzolamide profile page.
Summary for 020816
Tradename:AZOPT
Applicant:Novartis Pharms Corp
Ingredient:brinzolamide
Patents:0
Therapeutic Class:Ophthalmic Agents
Pharmacology for NDA: 020816
Mechanism of ActionCarbonic Anhydrase Inhibitors
Suppliers and Packaging for NDA: 020816
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZOPT brinzolamide SUSPENSION/DROPS;OPHTHALMIC 020816 NDA Alcon Laboratories, Inc. 0065-0275 N 0065-0275-25
AZOPT brinzolamide SUSPENSION/DROPS;OPHTHALMIC 020816 NDA Alcon Laboratories, Inc. 0065-0275 N 0065-0275-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrength1%
Approval Date:Apr 1, 1998TE:RLD:Yes

Expired US Patents for NDA 020816

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp AZOPT brinzolamide SUSPENSION/DROPS;OPHTHALMIC 020816-001 Apr 1, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp AZOPT brinzolamide SUSPENSION/DROPS;OPHTHALMIC 020816-001 Apr 1, 1998 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp AZOPT brinzolamide SUSPENSION/DROPS;OPHTHALMIC 020816-001 Apr 1, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Teva
Farmers Insurance
Chubb
Boehringer Ingelheim
Merck
Covington
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.